Author:
Aquilante Christina L.,Kosmiski Lisa A.,Bourne David W. A.,Bushman Lane R.,Daily Elizabeth B.,Hammond Kyle P.,Hopley Charles W.,Kadam Rajendra S.,Kanack Alexander T.,Kompella Uday B.,Le Merry,Predhomme Julie A.,Rower Joseph E.,Sidhom Maha S.
Subject
Pharmacology (medical),Pharmacology
Reference44 articles.
1. Evaluation of inhibitory drug interactions during drug development: genetic polymorphisms must be considered;Lee;Clin Pharmacol Ther,2005
2. Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance;Totah;Clin Pharmacol Ther,2005
3. Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies;Daily;Pharmacogenomics,2009
4. Clinical pharmacokinetics of pioglitazone;Eckland;Exp Clin Endocrinol Diabetes,2000
5. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone;Jaakkola;Clin Pharmacol Ther,2005
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献